Hydroxychloroquine + Vorinostat in Advanced Solid Tumors

NCT01023737 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Malignant Solid Tumour

Interventions

DRUG: Hydroxychloroquine
DRUG: Vorinostat

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]